Prosecution Insights
Last updated: April 19, 2026

Novaliq GmbH

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18377756 STABILISED PROTEIN COMPOSITIONS BASED ON SEMIFLUORINATED ALKANES KOSACK, JOSEPH R 3991 Non-Final OA Oct 06, 2023
18156749 SEMIFLUORINATED ALKANE COMPOSITIONS HOWELL, THEODORE R 1628 Non-Final OA Jan 19, 2023
17613832 OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY BRADLEY, CHRISTINA 1654 Final Rejection Nov 23, 2021
17350427 SEMIFLUORINATED COMPOUNDS MOU, LIYUAN 1628 Non-Final OA Jun 17, 2021
17297580 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACID ETHYL ESTERS MCKOY, QUINCY ANDRE 1626 Non-Final OA May 27, 2021

Managing Novaliq GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month